top of page
PRESS
Recardio at J.P. Morgan 2025
San Francisco, January 9, 2025 - Recardio Inc., a late-stage clinical-stage life science company focusing on therapies for cardiovascular...
Jan 91 min read
Â
Â
New International Patent Application
San Francisco, December 4, 2024 - Recardio Inc., a late stage clinical stage life science company developing therapies for cardiovascular...
Dec 4, 20242 min read
Â
Â
Recardio at LSX World Congress 2024
San Francisco, September 10, 2024 - Recardio Inc., a clinical-stage life science company focusing on regenerative therapies for...
Sep 10, 20241 min read
Â
Â
bottom of page